Thomas Stankovich, Former Vice President & CFO at Response Genetics, holds 22.95K shares in ReShape Lifesciences (Ticker: RSLS), holds 4.63K shares in ReShape Lifesciences (Ticker: ~RSLS), holds 67.49K shares in Response Genetics (Ticker: RGDXQ). Most recently, Thomas Stankovich Sold ― shares of ReShape Lifesciences on Nov 08, 2023 for an estimated value of 386.48.